Job-work valuation of physician's samples rests on transaction value, not pro rata MRP-based valuation.

Physician's samples manufactured on job-work basis and cleared to the principal manufacturer were to be valued on the actual transaction value between the job worker and the principal manufacturer, namely cost of raw materials plus job charges. The subsequent free distribution of the samples by the principal manufacturer did not justify a pro rata MRP-based valuation under Section 4A. Because the goods were not cleared free of cost by the job worker, the transaction value remained the proper basis of assessment. The demand based on pro rata MRP valuation was therefore not sustainable, and the consequential valuation-based demands and penalties were set aside.

---

---

Issues: Whether physician's samples manufactured on job work basis and cleared to the principal manufacturer were to be valued on transaction value based on cost of raw materials plus job charges, or on a pro rata MRP-based value under Section 4A.

Analysis: The appeals concerned physician's samples manufactured on job work basis and supplied to the principal manufacturer, who distributed them free of cost. The valuation adopted by the appellants was cost of production with job charges, while the Revenue sought to apply a pro rata value derived from MRP-based assessment of similar goods. The governing principle applied was that valuation must be based on the actual transaction between the job worker and the principal manufacturer, and not on the subsequent free distribution by the principal manufacturer. The goods were not cleared free of cost by the job worker, and the transaction value therefore remained the proper basis of assessment. Following the settled position affirmed by the higher court, Section 4A and the pro rata MRP-based approach were held inapplicable to these facts.

Conclusion: The physician's samples were correctly valued on transaction value consisting of cost of raw materials plus job charges, and the demand based on pro rata MRP valuation was not sustainable.

Final Conclusion: The appeals succeeded and the impugned valuation-based demands and consequential penalties were set aside.

Ratio Decidendi: Where physician's samples are manufactured on job work basis and sold to the principal manufacturer for consideration, valuation must be based on the actual transaction value and not on the principal manufacturer's subsequent free distribution or a pro rata MRP-based method.

---